The fungus fungus is one of the most important risk factors for stomach and mestizo diseases, with about half of the country ‘ s population infected, about 70 per cent without visible symptoms, 100 per cent with active stomach disease, about 10-20 per cent with digestive ulcer, and about 3-5 per cent with stomach cancer or lymphoma associated with gastric mucous membranes.
As a result, when adults become infected, they are generally recommended for eradication, with no countervailing factors, and are recommended for tetratherapy with a herbicide, but clinically there are still many who fail to eradicate.
High side effects, poor dependence, high drug resistance, declining eradication rates
There are now many global guidelines, as well as our fifth consensus, that recommend four-pronged treatments (two antibiotics + + PPI) containing americium as a front-line programme for adult infected persons.
The programme has significant shortcomings:
There are six recommended antibacterial drugs: Amocrin, tetracycline, furan acetone, carcinone, methazole, and left-oxidoxen.
High resistance (>20%) for three drugs (Cracin, Metrazine, Left Oxygen)
Three drugs (Amosilin, tetracyclics, furan acetone) have low resistance (<5%).
The side effects of the two substances (tetracyclics, fururant) are significant.
Tetracycline can cause oesophagus damage and photo-sensitization.
Furanketone can cause irreversible neuroflammation and severe skin reactions.
In addition, the eradication rate has fallen from 80 to 95 per cent to about 60 to 85 per cent, due to the patient ‘ s dependence, antibiotics and drug side effects, making it a priority to find new treatments.
I can’t cure the Quartet. Can you treat two drugs?
Yes, and eradication rate is 90%.
In 2020, the international authoritative magazine, Spectrum Spectrum, published a study on the use of the amoxicillin+PPI binary therapy, which cures the effects of the fungus on the roots of the fungus, better than the traditional tributary and the four-pronged treatments with americ agent.
The analysis included 12 random cross-reference studies (2249 patients) and, compared with the treatments recommended in the current mainstream clinical guidelines, the acid plus amoxicillin combination therapy, whether for initial or remedial treatment, has a better effect at 90.1 per cent eradication;
Furthermore, the incidence of adverse effects is low: 12.9 per cent of the combination therapy and 28 per cent of the traditional programme;
There is also a better treatment dependence due to the low incidence of adverse effects;
In a study in Taiwan, China, the United Amosilin 750 mg (4 days) dose of 20 mg (4 days) was used in Rebellaazine, with an eradication rate of 95.3 per cent among persons infected with Hp first treatment and 89.3 per cent among persons in rehab treatment. Studies such as Ren have compared the eradication rates for the different doses of Rebellaazole in the twin programmes, and have found that, in the case of the same dosages in Amocrin, the eradication rate for the use of Rebellaazole at three times per day was higher than the rate of Rebellaazole at 10 mg per day (ITT: 89.8 per cent vs. 75.9 per cent; PP: 93 per cent vs. 80 per cent). A study in Malaysia also used the Rebella 20 mg (3 days) joint Amosilin 1 g (3 days) method for the eradication of patients who have failed, and a more satisfactory eradication rate (ITT 71.8 per cent, PP 75.4 per cent).
A study in Shanghai, China, using the Asiomera 20 mg United Amosilin 750 mg (4 days/days), achieved a high eradication rate similar to that of the IVP (ITT 87.9 per cent, PP 91.1 per cent). Another Shanghai study, which gave the patient Asiomera 40 mg (2 days/days) a joint Amosilin 1 g (3 days/days), also achieved a high eradication rate (ITT 92.5 per cent, PP 96.1 per cent). A study in the Taiwan region of China, using Asiomera 40 mg United Amosilin 1,000 mg/day three times, found that the eradication rate of the large dosage twin programme group was significantly higher than that of the control group (ITT 91.7 per cent, PP 95.7 per cent). Graham, for example, gave Asiomera 40 mg (3 days/days) United Amosilin 750 mg (4 days/days) a eradication rate of 74 per cent. Graham believes that, in order to achieve a satisfactory eradication rate, PPI would need to give more than three times/day to be supplemented by sodium carbonate or a more effective PPI. A study in the Republic of Korea explored the granting of Asiomera 40 mg to patients in re-treatment, United Amosilin 1,000 mg (2 days), but failed to achieve a satisfactory eradication rate (66.7 per cent).
Thus, a high-dose PPI with a better eradication effect in the large dosage duplex consists of: Rebelazine 20 mg, 4 days or 3 days or 40 mg (3 days) or 20 mg (4 days). There are only two drugs, and the course of treatment is 14 days, and the cost of treatment has been significantly reduced.
